Macrophage activation by antiviral acyclic nucleoside phosphonates in dependence on priming immune stimuli

International Journal of Immunopharmacology

Volumn 22, Issue 12, 2000, Pages 1121-1129

  Zidek Z ^a   Frankova D ^a   Holy A ^b  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Acyclic nucleoside phosphonates; Adefovir; Interferon ; Interleukin 10; Lipopolysaccharide; Nitric oxide; Tenofovir; Tumor necrosis factor

Indexed keywords

ACYCLIC NUCLEOSIDE; ADEFOVIR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; GENOTYPE; IMMUNOMODULATION; IMMUNOSTIMULATION; INBRED STRAIN; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIVIRAL AGENTS; CYTOKINES; FEMALE; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NUCLEOSIDES; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034535364     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(00)00068-0     Document Type: Article

References (58)

1. Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients
2. Broad-spectrum anti-DNA virus and anti-retrovirus activity of phosphonomethoxyalkylpurines and -pyrimidines
3. Acyclic nucleotide analogues: Synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro
4. In vivo antiretroviral efficacy of oral bis(POM)-PMEA, the bis(pivaloyloxymethyl)prodrug of 9-(2-phosphonylmethoxyethyl)adenine (PMEA)
5. Phosphonomethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents
6. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine
7. Biphasic clearance kinetics of hepatitis B virus from patients during Adefovir dipivoxil therapy
8. Antiretroviral agent (R)-9-(2-phosphonomethoxypropyl)adenine stimulates cytokine and nitric oxide production
9. Immunomodulatory properties of antiviral acyclic nucleotide analogues: Cytokine stimulatory and nitric oxide costimulatory effects
10. Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base
11. Synthesis of enantiomeric N-(2-phosphonomethoxypropyl) derivatives of purine and pyrimidine bases. 1. The stepwise approach
12. Synthesis of N-(2-phosphonomethoxyethyl) derivatives of heterocyclic bases
13. Genetic variation in in-vitro cytokine-induced production of nitric oxide by murine peritoneal macrophages
14. Macrophage oxidation of L-arginine to nitrite and nitrate
15. Nitric oxide synthase: Expression and expressional control of the three isoforms
16. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
17. Transcriptional response to polypeptide ligands: The JAK-STAT pathway
18. NF-κB: Ten years after
19. Differences in nitric oxide synthase activity in a macrophage-like cell line, RAW 264.7 cells, treated with lipopolysaccharide (LPS) in the presence or absence of interferon-γ (IFN-γ): Possible heterogeneity of iNOS activity
20. Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precusor Ia of lipid A
21. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1
22. IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal phagocytes
23. Interferon gamma inhibits interleukin 10 production by monocytes
24. Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation
25. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
26. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase
27. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase
28. Role of nitric oxide synthesis in macrophage antimicrobial activity
29. Analysis of the role of CD4+ T-cells during murine cytomegalovirus infection in different strains of mice
30. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo
31. Inhibition of vesicular stomatitis virus infection by nitric oxide
32. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation
33. Interferon-g induced type I nitric oxide synthase activity inhibits viral replication in neurons
34. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line
35. Inhibition of influenza virus replication by nitric oxide
36. Constitutive activation of U937 promonocytic cell clones selected for their resistance to parvovirus H-1 infection
37. Inhibition of nitric oxide synthesis increases mortality in sindbis virus encephalitis
38. Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus
39. Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide
40. Interferon (IFN)α activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: Possible relationship of induced NOS2 to the anti-hepatitis C effects of IFNα in vivo
41. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection
42. Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance
43. CD4+ and CD8+ T cell interactions in IFN-gamma and IL-4 responses to viral infections: Requirements for IL-12
44. Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection
45. Regulation of macrophage growth and antiviral activity by interferon-gamma
46. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin
47. Role of interferon-γ in immune cell regulation
48. Cellular responses to interferon-γ
49. Macrophage nitric oxide synthase subunits: Purification, characterization and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme
50. New insights into the regulation of inducible nitric oxide synthase
51. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites
52. Role of IFN-γ-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells
53. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41
54. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease
55. Macrophages in mice acutely infected with lymphocytic choriomeningitis virus are primed for nitric oxide synthesis
56. Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients
57. Nitric oxide production induced by herpes simplex virus type 1 does not alter the course of the infection in human monocytic cells
58. Does nitric oxide play a critical role in viral infections?